Chemours (NYSE: CC - Get Free Report) and Bioceres Crop Solutions (NASDAQ: BIOX - Get Free Report) are both materials companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, profitability, dividends, analyst recommendations, institutional ownership, earnings and risk. Risk and Volatility Chemours has a beta of

Chemical stocks are flashing some of the highest dividend yields in the sector right now, but the number your screener shows and the check you will actually receive are not the same thing, and the gap between them hides a

DALLAS--(BUSINESS WIRE)--Baron & Budd has secured a $380 million settlement with DuPont, The Chemours Company, and Corteva on behalf of 11 North Carolina public entities to resolve claims arising from PFAS contamination. The entities - Bladen County, Brunswick County, Columbus County, Cumberland County, New Hanover County, Robeson County, Sampson County, Town of Wrightsville Beach, City of Lumberton, Village of Bald Head Island, and Lower Cape Fear Water and Sewer Authority – sought compens.

Chemours , DuPont and Corteva on Thursday reached a $455 million settlement with North Carolina and 11 ​local entities over PFAS contamination claims tied ‌to Chemours' Fayetteville Works plant and other historical discharges.

Resolves litigations brought by the State of North Carolina and 11 local entities relating to PFAS and other historical discharges from Fayetteville Works, as well as the State's claims of PFAS contamination unrelated to that site, including from the use of aqueous film forming foam ("AFFF"). Settlement payments over 15 years, with a net present value of approximately $355 million to be shared by DuPont, Chemours and Corteva.

Resolves litigations brought by the State of North Carolina and 11 local entities relating to PFAS and other historical discharges from Fayetteville Works, as well as the State's claims of PFAS contamination unrelated to that site, including from the use of aqueous film forming foam ("AFFF"). Overall settlement payments total $455 million over 15 years; Chemours' 50% share of payments of approximately $180 million on a net present value basis, which are covered by existing accruals.

Lululemon athletica (LULU) is experiencing significant pressure following its disappointing Q2 results, with shares dropping below $100 for the first time in se

Chemours (CC) reported earnings 30 days ago. What's next for the stock?

NEW YORK, Sept. 3, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company ("Chemours" or the "Company") (NYSE: CC).

NEW YORK, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company (“Chemours” or the “Company”) (NYSE: CC).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.